Kiadis Pharma B.V. , a clinical stage biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, today announces that it will organize a satellite symposium on The satellite symposium hosted by Kiadis Pharma is entitled: " Effective T-cell immunotherapy with ATIRa after haploidentical HSCT: Excellent OS with low GvHD " ... (more)
http://ift.tt/1lfPYXT
http://ift.tt/1lfPYXT
No comments:
Post a Comment